USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-0.17 | $-0.17 | $-0.19 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $30.00K | $68.00K | $136.40K |
Cardiff Oncology's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-0.18 | $-0.20 | $-0.16 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-0.66 | $-0.71 | $-0.62 |
| Dec 2022 | 4 | $-0.92 | $-1.15 | $-0.68 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.18 | $-0.17 | $-0.18 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.66 | $-0.64 | $-0.64 |
| Dec 2022 | 0 / 0 | $-0.92 | $-1.02 | $-1.01 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $30.00K | $0.00 | $70.00K |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $200.00K | $140.00K | $280.00K |
| Dec 2022 | 4 | $150.00K | $0.00 | $400.00K |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-0.17 | - | - |
| Aug 5, 2021 | Jun 2021 | $-0.15 | $-0.17 | -13.33% |
| May 6, 2021 | Mar 2021 | $-0.15 | $-0.14 | 5.08% |
| Feb 25, 2021 | Dec 2020 | $-0.14 | $-0.08 | 42.86% |
| Nov 5, 2020 | Sep 2020 | $-0.19 | $-0.19 | -1.77% |
| Aug 11, 2020 | Jun 2020 | $-0.24 | $-0.51 | -112.50% |
| May 7, 2020 | Mar 2020 | - | $-0.41 | - |
| Feb 27, 2020 | Dec 2019 | $-0.65 | $-0.51 | 21.54% |
| Nov 7, 2019 | Sep 2019 | $-0.84 | $-0.71 | 15.48% |
| Aug 8, 2019 | Jun 2019 | $-1.02 | $-0.79 | 22.55% |
| May 7, 2019 | Mar 2019 | $-1.07 | $-1.02 | 4.67% |
| Mar 6, 2019 | Dec 2018 | $-0.65 | $-1.09 | -67.69% |
| Nov 7, 2018 | Sep 2018 | $-1.98 | $-1.08 | 45.45% |
| Aug 3, 2018 | Jun 2018 | $-1.98 | $-2.76 | -39.39% |
| May 8, 2018 | Mar 2018 | $-5.76 | $-6.48 | -12.50% |
| Feb 26, 2018 | Dec 2017 | $-9.36 | $-4.32 | 53.85% |
| Nov 9, 2017 | Sep 2017 | $-10.08 | $-8.64 | 14.29% |
| Aug 9, 2017 | Jun 2017 | $-10.80 | $-18.72 | -73.33% |
| May 10, 2017 | Mar 2017 | $-17.28 | $-23.04 | -33.33% |
| Mar 15, 2017 | Dec 2016 | $-23.04 | $-20.16 | 12.50% |
| Nov 9, 2016 | Sep 2016 | $-23.76 | $-24.48 | -3.03% |
| Aug 4, 2016 | Jun 2016 | $-24.24 | $-24.48 | -0.99% |
| May 10, 2016 | Mar 2016 | $-23.40 | $-25.20 | -7.69% |
| Mar 10, 2016 | Dec 2015 | $-22.32 | $-18.72 | 16.13% |
| Nov 9, 2015 | Sep 2015 | $-0.27 | $-0.10 | 62.96% |
| Aug 10, 2015 | Jun 2015 | $-0.24 | $-0.41 | -70.83% |
| May 5, 2015 | Mar 2015 | $-0.24 | $-0.33 | -37.50% |
| Mar 12, 2015 | Dec 2014 | $-0.25 | $-0.25 | - |
| Nov 6, 2014 | Sep 2014 | $-0.24 | $-0.28 | -16.67% |
| Aug 7, 2014 | Jun 2014 | $-14.88 | $-4.32 | 70.97% |
| May 12, 2014 | Mar 2014 | $-14.04 | $-12.24 | 12.82% |
| Mar 17, 2014 | Dec 2013 | $-13.68 | $-3.60 | 73.68% |
| Nov 14, 2013 | Sep 2013 | $-16.20 | $-18.00 | -11.11% |
| Aug 14, 2013 | Jun 2013 | $-10.44 | $-10.80 | -3.45% |
| Apr 1, 2013 | Mar 2013 | $-6.12 | $-7.20 | -17.65% |
| Mar 31, 2013 | Dec 2012 | $-6.12 | $-7.20 | -17.65% |
| Nov 28, 2012 | Sep 2012 | - | $-3.35 | - |
| Aug 29, 2012 | Jun 2012 | - | $-20.47 | - |
| Mar 31, 2012 | Mar 2012 | - | $-7.67 | - |
| Dec 31, 2011 | Dec 2011 | - | $-9.32 | - |
| Sep 30, 2011 | Sep 2011 | - | $-0.00 | - |
| Jun 30, 2011 | Jun 2011 | - | $-4.12 | - |
| Mar 31, 2011 | Mar 2011 | - | $-3.94 | - |
| Jun 30, 2010 | Jun 2010 | - | $-6.21 | - |
| Mar 31, 2010 | Mar 2010 | - | $-4.44 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 25, 2021 | Dec 2020 | $-1.09 | $-1.19 | - |
| Feb 27, 2020 | Dec 2019 | - | $-3.03 | - |
| Mar 6, 2019 | Dec 2018 | - | $-11.41 | - |
| Feb 26, 2018 | Dec 2017 | - | $-54.72 | - |
| Mar 15, 2017 | Dec 2016 | - | $-94.32 | - |
| Mar 10, 2016 | Dec 2015 | - | $-19.56 | - |
| Mar 12, 2015 | Dec 2014 | - | $-17.09 | - |
| Mar 17, 2014 | Dec 2013 | - | $-39.60 | - |
| Mar 31, 2013 | Dec 2012 | - | $-38.69 | - |
| Dec 31, 2011 | Dec 2011 | - | $-28.02 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $30.00K | - | - |
| Aug 5, 2021 | Jun 2021 | $150.00K | $68.00K | 0.45% |
| May 6, 2021 | Mar 2021 | $150.00K | $72.00K | 0.48% |
| Feb 25, 2021 | Dec 2020 | $0.00 | $119.25K | - |
| Nov 5, 2020 | Sep 2020 | $30.00K | $136.40K | 4.55% |
| Aug 11, 2020 | Jun 2020 | $0.00 | $42.63K | - |
| May 7, 2020 | Mar 2020 | $0.00 | $67.70K | - |
| Feb 27, 2020 | Dec 2019 | - | $92.58K | - |
| Nov 7, 2019 | Sep 2019 | - | $51.69K | - |
| Aug 8, 2019 | Jun 2019 | - | $138.28K | - |
| May 7, 2019 | Mar 2019 | - | $161.96K | - |
| Mar 6, 2019 | Dec 2018 | - | $78.02K | - |
| Nov 7, 2018 | Sep 2018 | - | $88.36K | - |
| Aug 3, 2018 | Jun 2018 | - | $111.81K | - |
| May 8, 2018 | Mar 2018 | - | $100.14K | - |
| Feb 26, 2018 | Dec 2017 | - | $185.03K | - |
| Nov 9, 2017 | Sep 2017 | - | $123.33K | - |
| Aug 9, 2017 | Jun 2017 | - | $102.01K | - |
| May 10, 2017 | Mar 2017 | - | $95.04K | - |
| Mar 15, 2017 | Dec 2016 | - | $68.07K | - |
| Nov 9, 2016 | Sep 2016 | - | $89.11K | - |
| Aug 4, 2016 | Jun 2016 | - | $103.40K | - |
| May 10, 2016 | Mar 2016 | - | $120.49K | - |
| Mar 10, 2016 | Dec 2015 | - | $79.17K | - |
| Nov 9, 2015 | Sep 2015 | - | $57.33K | - |
| Aug 10, 2015 | Jun 2015 | - | $49.35K | - |
| May 5, 2015 | Mar 2015 | - | $126.97K | - |
| Mar 12, 2015 | Dec 2014 | - | $56.40K | - |
| Nov 6, 2014 | Sep 2014 | - | $57.20K | - |
| Aug 7, 2014 | Jun 2014 | - | $55.63K | - |
| May 12, 2014 | Mar 2014 | - | $110.95K | - |
| Mar 17, 2014 | Dec 2013 | - | $47.37K | - |
| Nov 14, 2013 | Sep 2013 | - | $43.76K | - |
| Aug 14, 2013 | Jun 2013 | - | $49.00K | - |
| Apr 1, 2013 | Mar 2013 | - | $119.12K | - |
| Mar 31, 2013 | Dec 2012 | - | $163.25K | - |
| Nov 28, 2012 | Sep 2012 | - | $211.50K | - |
| Aug 29, 2012 | Jun 2012 | - | $41.50K | - |
| Mar 31, 2012 | Mar 2012 | - | $34.15K | - |
| Dec 31, 2011 | Dec 2011 | - | $33.75K | - |
| Sep 30, 2011 | Sep 2011 | - | $55.00K | - |
| Jun 30, 2011 | Jun 2011 | - | $79.86K | - |
| Mar 31, 2011 | Mar 2011 | - | $89.08K | - |
| Jun 30, 2010 | Jun 2010 | - | $20.00K | - |
| Mar 31, 2010 | Mar 2010 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 25, 2021 | Dec 2020 | $366.00K | $365.99K | -0.00% |
| Feb 27, 2020 | Dec 2019 | - | $244.63K | - |
| Mar 6, 2019 | Dec 2018 | - | $378.32K | - |
| Feb 26, 2018 | Dec 2017 | - | $505.40K | - |
| Mar 15, 2017 | Dec 2016 | - | $381.07K | - |
| Mar 10, 2016 | Dec 2015 | - | $312.81K | - |
| Mar 12, 2015 | Dec 2014 | - | $280.18K | - |
| Mar 17, 2014 | Dec 2013 | - | $259.25K | - |
| Mar 31, 2013 | Dec 2012 | - | $450.40K | - |
| Dec 31, 2011 | Dec 2011 | - | $257.70K | - |
CRDF's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 4 analysts, the average EPS estimation for Cardiff Oncology's next quarterly earnings is $-0.17, with a low EPS estimation of $-0.19, and a high estimation of $-0.15.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.17, the last 2 month trend is $-0.17, and the 3 month trend is $-0.17.
Based on 4 analysts, the average revenue estimation is $30.00K, with a low revenue estimation of $0.00, and a high estimation of $70.00K.
Cardiff Oncology's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.
CRDF's earnings per share (EPS) was $-0.17, missing the consensus analysts forecast of $-0.15 by -13.33%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 21.43%, and higher than the same period a year before (Jun 2020) by -66.67%.
Revenues were $68.00K, worse than the forecast of $150.00K by -54.67%, down by -5.56% from the previous quarter , and up by 59.50% from the same period last year.
The company reported a net income of $-6.76M.Free cash flow for the quarter was $-4.30M , compared to $-5.88M last quarter and $-4.29M a year before.
CRDF ended the quarter with $408.00K in total debt, a decrease of -36.55% compared to the previous quarter, and an increase of 33.77% compared to the same quarter a year before.
Cardiff Oncology's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.
CRDF's earnings per share (EPS) was $-1.19, missing the consensus analysts forecast of $-1.09 by 9.17% , and higher than the previous year's EPS (Dec 2019) by -60.73%.
Revenues were $365.99K, worse than the forecast of $366.00K by -0.00%, and up by 49.61% from previous year's revenue.
The company reported a net income of $-19.31M.
Cardiff Oncology reported a free cash flow of $-16.53M for its fiscal year, compared to $-13.34M a year ago.
The company ended the fiscal year with $869.50K in total debt, a decrease of -49.63% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.